Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Johnson & Johnson gets grant for surgical instrument for harvesting tendon grafts
Johnson & Johnson has been granted a patent for a surgical instrument designed for harvesting tendon grafts. The instrument features...
Bedaquiline fumarate by Johnson & Johnson for Leprosy: Likelihood of Approval
Bedaquiline fumarate is under clinical development by Johnson & Johnson and currently in Phase II for Leprosy. According to GlobalData,...
Daratumumab by Johnson & Johnson for POEMS Syndrome (Crow-Fukase Syndrome): Likelihood of Approval
Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for POEMS Syndrome (Crow-Fukase Syndrome). According...
Cetrelimab by Johnson & Johnson for Hepatitis B: Likelihood of Approval
Cetrelimab is under clinical development by Johnson & Johnson and currently in Phase I for Hepatitis B. According to GlobalData,...
Seltorexant by Johnson & Johnson for Alzheimer's Disease: Likelihood of Approval
Seltorexant is under clinical development by Johnson & Johnson and currently in Phase II for Alzheimer's Disease. According to GlobalData,...
Lorpucitinib by Johnson & Johnson for Familial Adenomatous Polyposis: Likelihood of Approval
Lorpucitinib is under clinical development by Johnson & Johnson and currently in Phase I for Familial Adenomatous Polyposis. According to...
JNJ-4703 by Johnson & Johnson for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
JNJ-4703 is under clinical development by Johnson & Johnson and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According...
Mosnodenvir by Johnson & Johnson for Dengue Fever: Likelihood of Approval
Mosnodenvir is under clinical development by Johnson & Johnson and currently in Phase II for Dengue Fever. According to GlobalData,...
Lazertinib by Johnson & Johnson for Non-Small Cell Lung Cancer: Likelihood of Approval
Lazertinib is under clinical development by Johnson & Johnson and currently in Pre-Registration for Non-Small Cell Lung Cancer. According to...
JNJ-9280 by Johnson & Johnson for Inflammatory Bowel Disease: Likelihood of Approval
JNJ-9280 is under clinical development by Johnson & Johnson and currently in Phase I for Inflammatory Bowel Disease. According to...
Ustekinumab by Johnson & Johnson for Pouchitis: Likelihood of Approval
Ustekinumab is under clinical development by Johnson & Johnson and currently in Phase III for Pouchitis. According to GlobalData, Phase...
Risk adjusted net present value: What is the current valuation of Johnson & Johnson's Gemcitabine?
Gemcitabine is a small molecule commercialized by Johnson & Johnson, with a leading Phase III program in Non Muscle Invasive...
Risk adjusted net present value: What is the current valuation of Johnson & Johnson's Nipocalimab?
Nipocalimab is a monoclonal antibody commercialized by Johnson & Johnson, with a leading Phase III program in Acquired (Autoimmune) Hemolytic...
Johnson & Johnson gets grant for minimally invasive access device for intervertebral disc surgery
Johnson & Johnson has patented an access device for intervertebral disc surgery, combining direct visual microsurgical techniques with percutaneous methods....
JNJ-88549968 by Johnson & Johnson for Myeloproliferative Disorders: Likelihood of Approval
JNJ-88549968 is under clinical development by Johnson & Johnson and currently in Phase I for Myeloproliferative Disorders. According to GlobalData,...
JNJ-4703 by Johnson & Johnson for Sicca Syndrome (Sjogren): Likelihood of Approval
JNJ-4703 is under clinical development by Johnson & Johnson and currently in Phase II for Sicca Syndrome (Sjogren). According to...
JNJ-4703 by Johnson & Johnson for Rheumatoid Arthritis: Likelihood of Approval
JNJ-4703 is under clinical development by Johnson & Johnson and currently in Phase II for Rheumatoid Arthritis. According to GlobalData,...
JNJ-4703 by Johnson & Johnson for Ulcerative Colitis: Likelihood of Approval
JNJ-4703 is under clinical development by Johnson & Johnson and currently in Phase II for Ulcerative Colitis. According to GlobalData,...
Johnson & Johnson gets grant for expandable apparatus for electrophysiological sensing with staggered electrodes
Johnson & Johnson has been granted a patent for an apparatus designed for electrophysiological sensing. The apparatus includes a shaft...
Johnson & Johnson files patent for an apparatus for minimizing rotation of a staple driver
Johnson & Johnson has filed a patent for an apparatus that includes a staple, a body, a staple driver, and...